Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: A randomized controlled study

Pediatric Infectious Disease Journal

Volumn 24, Issue 8, 2005, Pages 676-679

  Levy, Itzhak ^a,b   Katz, Jacob ^a,b   Solter, Ester ^a,b   Samra, Zmira ^a,b   Vidne, Bernardo ^a,b   Birk, Einat ^a,b   Ashkenazi, Shai ^a,b   Dagan, Ovadia ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Central venous catheter colonization; Children; Chlorhexidine dressing; Prevention

Indexed keywords

CHLORHEXIDINE GLUCONATE; POLYURETHAN FOAM;

ACINETOBACTER; ADOLESCENT; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORYNEBACTERIUM DIPHTHERIAE; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HEART SURGERY; HUMAN; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL; SERRATIA; STREPTOCOCCUS PNEUMONIAE; WOUND DRESSING;

EID: 23744509364     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000172934.98865.14     Document Type: Article

References (32)

1. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 to June 2001: issued August 2001. Am J Infect Control. 2001;6:404-421.
2. Pittet P, Wendzel RP. Nosocomial bloodstream infections. Secular trends in mortality rates and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177-1184.
3. Norwood S, Ruby A, Civetta J, Cortes V. Catheter-related infections and associated septicemia. Chest. 1991;99:968-975.
4. Heiselman D. Nosocomial bloodstream infections in critically ill patients. JAMA. 1994;272:1819-1820.
5. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust. 1994;161:374-378.
6. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123-1133.
7. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled study. Arch Intern Med. 1998;158:473-477.
8. Raad II, Hohn DC, Gilbreath J, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231-238.
9. Maki DG, Stolzs M, Wheeler S, Mermel LA. Prevention of central venous catheter-related blood stream infections by use of an antiseptic impregnated catheter: a randomized controlled trial. Ann Intern Med. 1997;127:257-266.
10. George SJ, Vudamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol. 1997;14:428-431.
11. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial impregnated central venous catheters. N Engl J Med. 1999;340: 1-8.
12. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol. 1993;31:475-479.
13. Ljungman P, Hagglund H, Bhjorkstrand B, Lonnqvist B, Ringden O. Perioperative teicoplanin for prevention of Gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer. 1997;5:485-488.
14. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med. 1981;70:739-744.
15. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med. 1998; 26:1452-1457.
16. Mermel LA. Central venous catheter-related infections and their prevention: is there enough evidence to recommend tunneling for short-term use? [Editorial]. Crit Care Med. 1998;26:1315-1316.
17. Sovinz P, Urban C, Lackner H, Kerbi R, Schwinger W, Dormbusch HJ. Tunneled femoral central catheters in children with cancer. Pediatrics. 2001;107:e104.
18. O'Grady N, Alexander M, Dellinger P, et al. Guidelines for the prevention of intravascular catheter-related infections. Pediatrics. 2002;23: 759-769.
19. Hodge D, Puntis JWL. Diagnosis, prevention, and management of catheter-related bloodstream infection during long term parenteral nutrition. Arch Dis Child Fetal Neonatal Ed. 2002;87:F21-F24.
20. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery. 1982;92:720-725.
21. Mimoz O, Pieroni L, Lawrence C, et al. Prospective randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization or infection in intensive care unit patients. Crit Care Med. 1996;24:1818-1823.
22. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338: 339-343.
23. Hanazaki K, Shingu K, Adachi W, Miyazaki T, Amano J. Chlorhexidine dressing for reduction in microbial colonization of the skin with central venous catheters: a prospective randomized controlled trial. J Hosp Infect. 1999;42:165-168.
24. Gerland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001;107:1431-1436.
25. Maki DG, Mermel LA, Kluger DM, et al. The efficacy of chlorhexidine-impregnated sponge (Biopatch) for the prevention of intravascular catheter-related infection: a prospective randomized controlled multicenter trial. In: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2000, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000:422-424. Abstract 1430.
26. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an update Pediatric Risk of Mortality score. Crit Care Med. 1996;24:743-752.
27. Hannan EL, Racz M, Kavey RE, Quaegebeur JM, Williams R. Pediatric cardiac surgery: the effect of hospital and surgeon volume on in-hospital mortality. Pediatrics. 1998;101:963-969.
28. Maki DG, Weise CE, Sarafin HW. A semiquatitative culture method for identifying intravenous catheter-related infections. N Engl J Med. 1997; 296:1305-1309.
29. Bhende S, Spangler D. In vitro assessment of chlorhexidine gluconate-impregnated polyurethane foam antimicrobial dressing using zone of inhibition assays. Infect Control Hosp Epidemiol. 2004;25:664-667.
30. Roberts B, Cheung D. Biopatch: a new concept in antimicrobial dress-ings for invasive devices. Aust Crit Care. 1998;11:16-19.
31. Crawford AG, Fuhr JP, Rao B. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol. 2004;25:668-674.
32. Rijnders BA, Wijngaerden EV, Peetermans WE. Catheter tip colonization as a surrogate end-point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis. 2002;35:1053-1058.